New Insights into Potential Biomarkers in Patients with Mild Cognitive Impairment Occurring in the Prodromal Stage of Dementia with Lewy Bodies

Background: Prodromal dementia with Lewy bodies (DLB) can emerge with the onset of mild cognitive impairment (MCI). Standard biomarkers can help identify such patients to improve therapy and treatment strategies. Our review aims to describe the latest evidence on promising biomarkers in prodromal DL...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Niels, Bouter, Caroline, Müller, Sebastian Johannes, van Riesen, Christoph, Khadhraoui, Eya, Ernst, Marielle, Riedel, Christian Heiner, Wiltfang, Jens, Lange, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953759/
https://www.ncbi.nlm.nih.gov/pubmed/36831785
http://dx.doi.org/10.3390/brainsci13020242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953759/
https://www.ncbi.nlm.nih.gov/pubmed/36831785
http://dx.doi.org/10.3390/brainsci13020242

Ejemplares similares